Related Experiment Video

Updated: Apr 28, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

554

MicroRNAs in brain metastases: potential role as diagnostics and therapeutics

Samer Alsidawi1, Ehsan Malek2, James J Driscoll3

  • 1Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. alsidasr@ucmail.uc.edu.

International Journal of Molecular Sciences
|June 13, 2014
PubMed

Insights

MicroRNAs (miRNAs) are key regulators of brain metastasis. This review explores their potential as diagnostic and therapeutic targets for treating metastatic brain lesions, offering hope for improved patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Brain metastases significantly impact cancer patient survival, accounting for a substantial portion of cancer-related deaths.
  • The brain micro-environment influences metastatic tumor growth, but the specific genetic events driving this process remain unclear.
  • Non-coding RNAs, particularly microRNAs (miRNAs), play a crucial role in regulating tumor metastasis.

Purpose of the Study:

  • To review the potential of microRNAs (miRNAs) as diagnostic and therapeutic targets for metastatic brain lesions.
  • To highlight the role of miRNAs in distinguishing between normal and cancerous cells, and in categorizing metastatic brain tumors.
  • To discuss the promise of miRNA-based therapies for improving patient outcomes in brain metastasis treatment.

Main Methods:

  • Literature review focusing on the role of miRNAs in brain metastasis.
  • Analysis of studies demonstrating miRNA profiling for cancer cell and tumor classification.
  • Examination of research on miRNA manipulation for cancer treatment efficacy.

Main Results:

  • miRNA profiles can accurately distinguish normal from cancerous cells and classify metastatic brain tumors by origin.
  • Manipulation of miRNAs has shown effectiveness in preclinical cancer treatment models.
  • miRNAs hold promise for developing targeted, personalized anti-cancer therapies with reduced toxicity.

Conclusions:

  • MicroRNAs (miRNAs) are critical regulators in the development and progression of brain metastases.
  • miRNAs offer significant potential as biomarkers for diagnosing and classifying brain metastases.
  • Targeting miRNAs presents a promising therapeutic strategy to improve treatment efficacy and patient outcomes for brain metastases.

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

866
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

17.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K